ask="6.80"
ask_size="100"
average_daily_volume="185327"
bid="2.60"
bid_size="400"
book_value="0.00"
change="-0.14"
change_from_200_day_moving_average="-0.03"
change_from_50_day_moving_average="0.03"
change_from_52_week_high="-4.74"
change_From_52_week_low="1.93"
change_in_percent="-2.73%"
close="4.98"
dividend_pay_date="8/1/2016"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.18"
ebitda="0.00"
eps_estimate_current_year="-3.89"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-5.48"
ex_dividend_date="N/A"
float_shares="N/A"
high="5.14"
high_52_weeks="9.72"
last_trade_date="2/2/2017"
last_trade_price="4.98"
last_trade_size="100"
last_trade_time="3:59pm"
low="4.82"
low_52_weeks="3.05"
market_capitalization="N/A"
moving_average_200_day="5.01"
moving_average_50_day="4.95"
name="Cyclacel Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="60.00"
open="5.12"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-0.67%"
percent_change_from_50_day_moving_average="+0.70%"
percent_change_from_52_week_high="-48.77%"
percent_change_from_52_week_low="+63.28%"
previous_close="5.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NCM"
symbol="CYCC"
volume="18600"
weeks_range_52="3.05 - 9.72"
